Elevated c-Src activity leads to inhibition of matrix metalloproteinases (Noritake et al, 1999), disruption of cell–cell adhesions (Yeatman, 2004) and enhances the migratory potential of tumour cells (Frame, 2002). This evidence concerns the gene SRC and neoplasm.